The FDA has approved Exdensur depemokimab-ulaa as an add-on maintenance therapy for severe asthma in patients aged 12 and older, supported by Phase III SWIFT trial data showing significant reductions ...

Examine how evolving sourcing strategies, functional standardization, and system choices can help sponsors support sites more ...

In today’s ACT Brief, we examine new survey data revealing what patients value most in remote clinical trials, break down ...

This case study highlights Quest Diagnostics' successful and cost-effective patient recruitment for The Michael J. Fox Foundation's Parkinson's study. By using its extensive patient network, Quest ...